Ana Laus to Genetic Predisposition to Disease
This is a "connection" page, showing publications Ana Laus has written about Genetic Predisposition to Disease.
Connection Strength
0.424
-
de Carvalho AC, Laus AC, Lopes Junior HR, Porto J, Sant'Anna Silva D, Ribeiro AG, Datorre JG, Tavares RM, Sousa Carlos AB, Furquim T, Uno M, Chammas R, Villela P, Dos Reis MB, de Medeiros Matsushita M, Oliveira MA, Hirai WY, Guimar?es DP, Santos FA, Reis RM. Association of Genetic Ancestry and Colorectal Cancer Risk in a Large Brazilian Cohort: Replication of Single-Nucleotide Polymorphisms Identified by Genome-Wide Association Studies. JCO Glob Oncol. 2025 Jun; 11:e2400512.
Score: 0.179
-
Leal LF, Laus AC, Cavagna R, de Paula FE, de Oliveira MA, Ribeiro DM, Hassan FM, Miziara JE, da Silva ECA, da Silva VD, De Marchi P, Reis RM. EGF+61 A>G polymorphism does not predict response to first-generation EGFR tyrosine kinase inhibitors in lung cancer patients. Thorac Cancer. 2020 10; 11(10):2987-2992.
Score: 0.129
-
Laus AC, de Paula FE, de Lima MA, Carlos CD, Gomes INF, de Marchi P, Valente JKN, Pioltini ABM, Miziara JE, da Silva CM, Viana LS, Scapulatempo-Neto C, Reis RM. EGF+61 A>G polymorphism is not associated with lung cancer risk in the Brazilian population. Mol Biol Rep. 2019 Apr; 46(2):2417-2425.
Score: 0.116